Characteristic | n (%) |
No. of patients | 39 |
Median age (y) | 62 (range, 31–90) |
Race | |
African American | 4 (10) |
Asian | 3 (8) |
Caucasian | 31 (79) |
Other | 1 (3) |
Histology | |
Ductal | 37 (95) |
Adenoid cystic | 1 (3) |
Papillary | 1 (3) |
Tumor grade | |
High | 28 (72) |
Intermediate | 9 (23) |
Unknown | 2 (5) |
Receptor status | |
ER+/HER2− | 33 (84) |
HER2+ | 5 (13) |
Triple-negative | 1 (3) |
BRCA1 or 2 mutation | |
Yes | 4 (10) |
No | 16 (41) |
Unknown | 19 (49) |
Initial staging | |
Pre-PET/CT stage | |
I | 2 (5) |
IIA | 6 (15) |
IIB | 19 (49) |
IIIA | 5 (13) |
IIIB | 4 (10) |
IIIC | 3 (8) |
T stage | |
T1 | 5 (13) |
T2 | 29 (74) |
T3 | 1 (3) |
T4 | 4 (10) |
N stage | |
N0 | 10 (26) |
N1 | 22 (56) |
N2 | 4 (10) |
N3 | 3 (8) |
M stage, M0 | 39 (100) |
Data in parentheses are percentages, unless otherwise indicated.